Skip to main content

Table 1 KRAS mutations examined samples

From: KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay

mutation amino acid n %
GGT → GAT gly12 → asp12 24 40
GGT → TGT gly12 → cys12 8 13
GGT → GTT gly12 → val12 14 23
GGT → GCT gly12 → ala12 4 7
GGT → CGT gly12 → arg12 2 3
GGC → GAC gly13 → asp13 4 7
GGC → TGC gly13 → cys13 1 2
GGT → GCT/GAT gly12 → ala12/asp12 2 3
GGT → GTT/GAT gly12 → val12/asp12 1 2
  total 60 100